Thursday, April 25, 2013

• Geron Updates Imetelstat Development Strategy, Including Progress of Investigator-Sponsored Study in MyelofibrosisThomson Reuters ONE( (Thu, Apr 25)

Wednesday, April 24, 2013

• Geron to Present at the Needham Healthcare ConferenceThomson Reuters ONE( (Wed, Apr 24)

Monday, April 22, 2013

• Geron Announces Conference Call to Discuss First Quarter 2013 Financial ResultsThomson Reuters ONE( (Mon, Apr 22)

Tuesday, April 9, 2013

• Geron Announces Presentations at the American Association for Cancer Research Annual MeetingThomson Reuters ONE( (Tue, Apr 9)

Tuesday, March 12, 2013

• Geron Corporation Reports Fourth Quarter and Annual 2012 Financial ResultsThomson Reuters ONE( (Tue, Mar 12)
• Programs by the FDA Designed to Speed up Approval Process for Critical Drugs a Key Factor in Biotech's Industry SuccessMarketwired( (Tue, Mar 12)

Tuesday, March 5, 2013

• Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2012 Financial ResultsThomson Reuters ONE( (Tue, Mar 5)

Wednesday, February 27, 2013

• Geron to Present at the Cowen and Company Health Care ConferenceThomson Reuters ONE( (Wed, Feb 27)

Wednesday, February 6, 2013

• Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's SuccessMarketwired( (Wed, Feb 6)

Friday, January 11, 2013

• Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With CashMarketwired( (Fri, Jan 11)

Tuesday, November 20, 2012

• Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate IncreasesMarketwired( (Tue, Nov 20)

Thursday, October 25, 2012

• FDA Considering Allowing Developers of Critical Drugs/Treatments to Conduct Smaller, Faster Clinical TrialsMarketwired( (Thu, Oct 25)

Tuesday, October 2, 2012

• Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint VenturesMarketwired( (Tue, Oct 2)